Clinical trial
A Phase II Study of Oxaliplatin Capecitabine and Pre-operative Radiotherapy for…
NCT00220051 · Royal Marsden NHS Foundation Trust, Other · Completed
Key facts
| NCT number | NCT00220051 |
|---|---|
| Title | A Phase II Study of Oxaliplatin Capecitabine and Pre-operative Radiotherapy for Patients With Locally Advanced and Inoperable Rectal Cancer |
| Official title | A Phase II Study of Oxaliplatin (Eloxatin) Capecitabine (Xeloda) and Pre-operative Radiotherapy for Patients With Locally Advanced and Inoperable Rectal Cancer. |
| Lead sponsor | Royal Marsden NHS Foundation Trust, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Rectal Cancer |
| Intervention type | Drug, Procedure |
| Interventions | Oxaliplatin, Capecitabine, Pre operative radiotherapy, Surgical Resection |
| Enrollment | 109 |
| Start date | Nov 1, 2001 |
| First posted | Sep 22, 2005 |
| Last update posted | May 31, 2013 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: